Clinical Trial: Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763899) titled 'Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.' on Aug. 10.

Brief Summary: Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study.

Study Start Date: Nov. 19, 2025

Study Type: INTERVENTIONAL

Condition: Bioequivalance

Intervention: DRUG: Test

Metformin/sitagliptin, 50 mg/1000 mg, ER tablet

DRUG: Reference

Janumet XR, 50 mg/1000 mg, ER tablet

Recruitment Status: COMPLETED

Sponsor: ADIUM

Published by HT D...